NEW YORK (GenomeWeb) – Circulomics today announced the National Institutes of Health has awarded it a Phase I Small Business Innovation Research grant to develop its new Nanobind DNA/RNA extraction technology.
The six-month grant is for $175,000, the company's CEO Kelvin Liu told GenomeWeb Daily News.